Douglas Vincent Faller Buys Shares of IMNN
Chief Medical Officer Douglas Vincent Faller purchased 21,896 shares of IMNN.
Key Points
- Douglas Vincent Faller, Chief Medical Officer of IMNN, bought 21,896 shares at $1.72, totaling $37,661.12 on June 25, 2026.
- Shares of IMNN traded near $1.80 on Tuesday, reflecting recent insider buying activity.
- Analysts from Maxim Group and others maintain a buy rating, with price targets up to $29.00.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Douglas Vincent Faller, the Chief Medical Officer at IMNN, recently bought 21,896 shares of the company at an average price of $1.72 each. This purchase, made on June 25, 2026, was valued at $37,661.12. The transaction wasn't part of a pre-planned trading program.
Insider Buying and Selling at Imunon, Inc.
In addition to Faller's purchase, other executives at IMNN were active in acquiring shares. Michael Tardugno, Executive Chairman of the Board, bought 42,519 shares at $1.72 on June 25, 2026, and additional shares earlier in the month at $1.82 and $2.06. Stacy Lindborg, President and CEO, purchased 67,150 shares at $1.72 and 1,803 shares at $1.82 in June.
Other Institutional Activity in IMNN
Armistice Capital, LLC increased its holdings in IMNN by 81,444 shares, ending with 348,330 shares valued at approximately $1,024,090, marking a 30.5% increase. Vanguard Capital Management LLC opened a new position with 48,056 shares worth about $141,285. Geode Capital Management, LLC also boosted its position by 11,989 shares to a total of 33,211 shares valued at $97,644.
Imunon, Inc. Stock Up 12.5%
Shares of IMNN traded near $1.80 on Tuesday. The company has been attracting attention with recent insider buying activities. While specific financial metrics aren't available, the stock's trading price reflects recent market movements and investor interest.
$IMNN stock price
Daily closing prices, year to date. Not investment advice.
Analysts Set New Price Targets
On April 17, 2026, Maxim Group initiated coverage on IMNN with a buy rating and set a price target of $10.00. Other analysts, including D. Boral Capital and HC Wainwright & Co., have maintained a buy rating, with targets reaching as high as $29.00.
Bottom Line
Douglas Vincent Faller's recent purchase of IMNN shares highlights insider confidence in the company's prospects. Such transactions are often watched closely by investors as they can provide insights into the company's future. Analysts continue to support the stock with buy ratings and high price targets, suggesting optimism about its potential.
Get Imunon, Inc. alerts
New 13F filings, insider trades, and analyst moves on $IMNN, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.